ICR welcomes appointment of Aviva and Socius for new life-sciences development at The London Cancer Hub 22 Jan 2024 The Institute of Cancer Research has welcomed the appointment of a new partnership to deliver a major redevelopment project at The London Cancer Hub in Sutton. Find out more Show/Hide
ICR-discovered drug to enter phase II clinical trial in ovarian cancer thanks to new research collaboration 04 May 2023 An innovative cancer drug discovered by scientists at The Institute of Cancer Research, London, is set to enter a new clinical trial. Find out more Show/Hide
Immuno-oncology collaboration to develop innovative new type of cancer drug 18 Apr 2023 Scientists at The Institute of Cancer Research, London, are teaming up with small molecule neoantigen immuno-oncology company NeoPhore to develop new potential cancer drugs. Find out more Show/Hide